aMedical Oncology Unit, Integrated University Hospital of Verona (AOUI), Verona
bMedical Oncology Division of Urogenital and Head & Neck Tumours, European Institute of Oncology
cHumanitas Clinical and Research Center, Humanitas Cancer Center, Rozzano
dNiguarda Cancer Center, Great Niguarda Metropolitan Hospital, Milan
eDepartment of Medical Oncology 2, AOUP, Tuscan Cancer Institute (ITT), Pisa
fDepartment of Oncology and Haematology and Respiratory Disease, University Hospital, Modena
gDepartment of Medical Oncology, Scientific Institute Romagnolo for the Study and Treatment of Tumors (IRST) IRCCS, Meldola
hDepartment of Medical Oncology, Campus Bio-Medico University of Rome, Rome
iDepartment of Uro-Gynaecological Oncology, Division of Medical Oncology, National Cancer Institute – IRCCS – G. Pascale Foundation, Napoli
jDepartment of Medical Oncology & Urology, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara
kMedical Oncology Unit, Civil Hospital – University Hospital of Cagliari, Cagliari
lDepartment of Medical Oncology, IRCCS University Hospital San Martino – IST National Institute for Cancer Research, Genova
mDivision of Oncology, S.Orsola-Malpighi Hospital, Bologna
nMedical Oncology Unit, University Hospital of Parma, Parma
oMedical Oncology Unit, Arcispedale Santa Maria Nuova, IRCCS, Reggio Emilia
pDepartment of Medical Oncology, IRCCS, San Matteo University Hospital Foundation, Pavia, Italy
Correspondence to Roberto Iacovelli, MD, PhD, Medical Oncology Unit, Integrated University Hospital of Verona (AOUI), Piazzale L.A. Scuro 10, 37134 Verona, Italy Tel: +39 045 812 115; fax: +39 045 802 7410; e-mail: [email protected]
Received December 19, 2017
Accepted March 17, 2018